Phio Pharmaceuticals Corp. (PHIO) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 1K | 0 | 0 | 1.07M | 0 | 0 | 644K | 866K | 0 | 43K | 1.81M | 49K | 2.13M | 1.61M | 2.51M | 1.3M | 1.59M | 2.23M | 2.67M | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -1K | 0 | 0 | -1.07M | 0 | 0 | -644K | -866K | 0 | -43K | -1.81M | -49K | -2.13M | -1.61M | -2.51M | -1.3M | -1.59M | -2.23M | -2.67M | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | 100% | -24.02% | - | 100% | 64.38% | -1667.35% | 100% | 97.34% | 27.91% | 96.24% | -34.55% | 27.46% | 6.17% | - | 34.71% | -4844.44% | -112.82% | 100% |
| Operating Expenses | 4.17M | 2.53M | 2.5M | 1.24M | 1.87M | 1.67M | 946K | 1.05M | 2.21M | 1.73M | 968K | 2.5M | 1.47M | 1.12M | 1.06M | 1.22M | 1.05M | 1.23M | 1.07M | 2.68M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 1.37M | 1.06M | 1.32M | 1.24M | 986K | 689K | 946K | 1.05M | 1.06M | 723K | 968K | 1.16M | 1.47M | 1.12M | 1.06M | 1.22M | 1.05M | 1.23M | 1.07M | 1.13M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 2.79M | 1.48M | 1.18M | 1.07M | 886K | 985K | 644K | 866K | 1.15M | 1.01M | 1.81M | 1.38M | 2.13M | 1.61M | 2.51M | 1.3M | 1.59M | 2.23M | 2.67M | 1.56M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | -1000K | 0 | 0 | -644K | -866K | 0 | 0 | -1000K | -49K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | 0 |
| Operating Income | -4.17M | -2.53M | -2.5M | -2.31M | -1.87M | -1.67M | -1.59M | -1.91M | -2.21M | -1.77M | -2.78M | -2.55M | -3.6M | -2.73M | -3.57M | -2.52M | -2.64M | -3.45M | -3.74M | -2.68M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -122.6% | -51.37% | -57.55% | -20.64% | 15.26% | 5.58% | 42.72% | 24.85% | 38.67% | 35.05% | 22.26% | -1.03% | -36.44% | 20.87% | 4.49% | 6.07% | 27.43% | -40.13% | -62.14% | -60.81% |
| EBITDA | -4.17M | -2.53M | -2.5M | -2.31M | -1.77M | -1.63M | -1.59M | -1.91M | -2.17M | -1.73M | -2.76M | -2.53M | -3.59M | -2.71M | -3.56M | -2.5M | -2.62M | -3.43M | -3.72M | -2.67M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -135.5% | -55.78% | -57.42% | -20.67% | 18.67% | 6.01% | 42.41% | 24.45% | 39.35% | 36.28% | 22.36% | -1.2% | -36.97% | 20.85% | 4.41% | 6.15% | 27.68% | -41.91% | -62.59% | -61.58% |
| D&A (Non-Cash Add-back) | 1K | 1K | 2K | 500 | 0 | 0 | 0 | 1K | 34K | 43K | 15K | 15K | 16K | 15K | 15K | 19K | 22K | 20K | 19K | 18K |
| EBIT | -4.17M | -2.53M | -2.5M | -2.31M | -1.77M | -1.63M | -1.59M | -1.91M | -2.21M | -1.9M | -2.78M | -2.55M | -3.6M | -2.73M | -3.57M | -2.52M | -2.64M | -3.45M | -3.74M | -2.68M |
| Net Interest Income | 161K | 0 | 0 | 119K | 125K | 231K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5K | -10K | -2K | -1K | -3K | -3K |
| Interest Income | 161K | 0 | 0 | 119K | 125K | 231K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5K | 10K | 2K | 1K | 3K | 3K |
| Other Income/Expense | 164K | 163K | 113K | 143K | 103K | 48K | 66K | 68K | 55K | -122K | -4K | -2K | 0 | -1K | -5K | -10K | -2K | -1K | -3K | -3K |
| Pretax Income | -4M | -2.37M | -2.39M | -2.17M | -1.77M | -1.63M | -1.52M | -1.85M | -2.15M | -1.9M | -2.78M | -2.55M | -3.6M | -2.73M | -3.58M | -2.53M | -2.64M | -3.45M | -3.74M | -2.69M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -4M | -2.37M | -2.39M | -2.17M | -1.77M | -1.63M | -1.52M | -1.85M | -2.15M | -1.9M | -2.78M | -2.55M | -3.6M | -2.73M | -3.58M | -2.53M | -2.64M | -3.45M | -3.74M | -2.69M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -126.29% | -45.82% | -56.96% | -17.33% | 17.87% | 14.2% | 45.18% | 27.58% | 40.2% | 30.61% | 22.26% | -0.71% | -36.34% | 20.86% | 4.44% | 5.81% | 22.45% | -40.17% | -62.06% | -60.71% |
| Net Income (Continuing) | -4M | -2.37M | -2.39M | -2.17M | -1.77M | -1.63M | -1.52M | -1.85M | -2.15M | -1.9M | -2.78M | -2.55M | -3.6M | -2.73M | -3.58M | -2.53M | -2.64M | -3.45M | -3.74M | -2.69M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.34 | -0.20 | -0.44 | -0.45 | -41070.15 | -0.37 | -1.54 | -3.62 | -4.24 | -4.56 | -10.26 | -13.29 | -28.41 | -20.52 | -28.33 | -20.11 | -21.07 | -27.57 | -29.89 | -21.46 |
| EPS Growth % | 100% | 45.95% | 71.43% | 87.57% | -968535.61% | 91.89% | 84.99% | 72.76% | 85.08% | 77.78% | 63.78% | 33.91% | -34.84% | 25.57% | 5.22% | 6.29% | 38.91% | 40.13% | 30.78% | 41.04% |
| EPS (Basic) | -0.34 | -0.20 | -0.44 | -0.45 | -41070.15 | -0.37 | -1.54 | -3.62 | -4.24 | -4.56 | -10.26 | -13.29 | -28.41 | -20.52 | -28.33 | -20.11 | -21.07 | -27.57 | -29.89 | -21.46 |
| Diluted Shares Outstanding | 11.62M | 11.62M | 5.47M | 4.79M | 4.31M | 787.47K | 990.03K | 510.19K | 508.39K | 415.95K | 270.86K | 191.86K | 126.78K | 126.43K | 126.38K | 126.34K | 125.47K | 125.19K | 125.19K | 125.19K |
| Basic Shares Outstanding | 11.62M | 11.62M | 5.47M | 4.79M | 4.31M | 787.47K | 990.03K | 510.19K | 508.39K | 415.95K | 270.86K | 191.86K | 126.78K | 126.43K | 126.38K | 126.34K | 125.47K | 125.19K | 125.19K | 125.19K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |